Charles Kelly
Papers
2
Total Citations
22
H-Index
2
About
Charles Kelly is a pioneering head and neck surgeon whose work has advanced the field of transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of human papillomavirus (HPV)-related disease. As a key figure at the first TORS practice to commence in the United Kingdom, Kelly’s research has established foundational protocols for robotic-assisted treatment. His most cited work, a 2021 observational single-centre series (15 citations), provides critical evidence on oncological outcomes following primary TORS with or without adjuvant therapy, demonstrating the safety and efficacy of this minimally invasive approach in a large UK cohort. An earlier 2018 study (7 citations) further validated the oncological safety of robotic lateral oropharyngectomy after diagnostic tonsillectomy in high-risk HPV-positive patients. These contributions have helped shape clinical guidelines, offering patients reduced morbidity compared to traditional open surgery while maintaining excellent cancer control. Kelly’s work is essential reading for surgeons and oncologists seeking to understand the real-world application of TORS, cementing his reputation as a leader in robotic head and neck surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2